Skip to content
value.today

Patara Pharma, LLC

🇺🇸 San Diego, California, USABiotechnologyFounded 2013
Total raised
$32 M
3 rounds on record
Latest round
$6 M
Sep 2016
First round on record
Jan 2014
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Patara Pharma, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2016$6 MNo. 3$2 to $10 million

Patara Pharma, LLC: Raise no. 3, Sep 2016

Investors in this round

37 investors had bought by the notice of Oct 13, 2016: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • William M. Gerhart · Executive Officer, Director, Promoter · Managing Member of Managing Member of the Issuer; CEO of Issuer
  • N/A Bernoulli Pharma Holdings, LLC · Director, Promoter · Managing Member of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William M. Gerhart, Managing Member of Managing Member of Issuer. Source: SEC Form D, newest notice filed Oct 13, 2016. Read the notice at the SEC.

equitySEC
Aug 2014$24 MNo. 2$10 to $50 million

Patara Pharma, LLC: Raise no. 2, Aug 2014

Investors in this round

49 investors had bought by the notice of Oct 14, 2015: 49 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • William M. Gerhart · Executive Officer, Director, Promoter · Managing Member of Managing Member of the Issuer; CEO of Issuer
  • N/A Bernoulli Pharma Holdings, LLC · Director, Promoter · Managing Member of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William M. Gerhart, Managing Member of Managing Member of Issuer. Source: SEC Form D and 1 amendment, newest notice filed Oct 14, 2015. Read the notice at the SEC.

equitySEC
Jan 2014$2 MNo. 1Under $2 million

Patara Pharma, LLC: Raise no. 1, Jan 2014

Investors in this round

28 investors had bought by the notice of Feb 4, 2014: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, debt, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • William M. Gerhart · Executive Officer, Director, Promoter · Managing Member of Managing Member of the Issuer; CEO of Issuer
  • N/A Bernoulli Pharma Holdings, LLC · Director, Promoter · Managing Member of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The offering includes (A) (i) Convertible Promissory Notes (convertible into Series A Pref. Units or Class A Common Units) and (ii) Class A Common Units issued for cash, and (B) Class B Common Units issued for services (no cash proceeds).”

Signed by William M. Gerhart, Managing Member of Managing Member of Issuer. Source: SEC Form D, newest notice filed Feb 4, 2014. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Patara Pharma, LLC chose not to state its revenue in its newest notice of a funding round (Oct 2016).

    SEC Form D · Oct 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2016

That is all the official record says: Patara Pharma, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Patara Pharma, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 49 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Patara Pharma, LLC
NameRoleNamed in
William M. GerhartManaging Member of Managing Member of the Issuer; CEO of IssuerOct 2016
N/A Bernoulli Pharma Holdings, LLCManaging Member of the IssuerOct 2016
William M. GerhartManaging Member of Managing Member of the Issuer; CEO of IssuerOct 2016
N/A Bernoulli Pharma Holdings, LLCManaging Member of the IssuerOct 2016
William M. GerhartManaging Member of Managing Member of the Issuer; CEO of IssuerOct 2016